<DOC>
	<DOCNO>NCT02600156</DOCNO>
	<brief_summary>The primary purpose study evaluate feasibility safety MRI-guided focal laser ablation ( Laser-Induced Interstitial Thermal Therapy , LITT ) treat low-risk native prostate cancer .</brief_summary>
	<brief_title>Focal Laser Ablation Prostate Cancer Tumors</brief_title>
	<detailed_description>The study do evaluate safety effectiveness Magnetic Resonance Imaging ( MRI ) -guided focal laser therapy Visualase Thermal Therapy System treat low-risk prostate cancer tumor . Unlike surgery radiotherapy affect large portion prostate entire organ , localized focal therapy intend treat small portion tissue cancer find biopsy .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Inclusion Criteria Male , 45 year age old . Diagnosis prostate adenocarcinoma . Clinical stage T1c T2a . Gleason score 7 ( 3+4 4+3 ) le . Three few biopsy core prostate cancer . No single biopsy core great 50 % tumor involvement . One , two , three tumor suspicious region identify multiparametric MRI Negative radiographic indication extracapsular extent . A documented Karnofsky performance status least 70 . Estimated survival 5 year great , determine treat physician . Tolerance anesthesia/sedation . Ability give inform consent . MRguided biopsy confirmation one radiographically visible prostate lesion ( ) Gleason score 7 ( 3+4 4+3 ) less . Exclusion Criteria Presence condition ( e.g. , metal implant , shrapnel ) compatible MRI . History primary nonskin malignancy within previous three year .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>